Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications
A global threat has emerged in 2019 due to the rapid spread of Coronavirus disease
(COVID-19). As of January 2021, the number of cases worldwide reached 103 million cases …
(COVID-19). As of January 2021, the number of cases worldwide reached 103 million cases …
Drug repurposing and cytokine management in response to COVID-19: A review
L Heimfarth, MR Serafini, PR Martins-Filho… - International …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), the infectious disease caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an aggressive disease …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an aggressive disease …
[HTML][HTML] Drug Repurposing for COVID-19 Therapy
R Maldonado, F Drago - Frontiers in Pharmacology, 2021 - frontiersin.org
The rapid emergence in December 2019 of cases of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection in China rapidly expanded to multiple countries …
coronavirus 2 (SARS-CoV-2) infection in China rapidly expanded to multiple countries …
Clinical features and mechanistic insights into drug repurposing for combating COVID-19
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged from Wuhan in
China before it spread to the entire globe. It causes coronavirus disease of 2019 (COVID-19) …
China before it spread to the entire globe. It causes coronavirus disease of 2019 (COVID-19) …
[HTML][HTML] SARS-CoV-2: virology and drug repurposing approaches
R Rahmasari, H Setiawan, RR Syahdi… - Pharmaceutical …, 2020 - scholarhub.ui.ac.id
An emerging coronavirus, SARS-CoV-2, is the causative agent for the ongoing pandemic of
coronavirus disease 2019 (COVID-19), which has caused a worldwide social and economic …
coronavirus disease 2019 (COVID-19), which has caused a worldwide social and economic …
[HTML][HTML] An update on antiviral therapy against SARS-CoV-2: how far have we come?
O Indari, S Jakhmola, E Manivannan… - Frontiers in …, 2021 - frontiersin.org
COVID-19 pandemic has spread worldwide at an exponential rate affecting millions of
people instantaneously. Currently, various drugs are under investigation to treat an …
people instantaneously. Currently, various drugs are under investigation to treat an …
Repositioning of Drugs to Counter COVID-19 Pandemic-An Insight
SM Akilesh, D Palanisamy… - Current pharmaceutical …, 2021 - ingentaconnect.com
COVID-19 is a pandemic, caused by the novel coronavirus 2 (SARS-CoV-2) which is a
severe acute respiratory syndrome. The devastating impact of this novel coronavirus …
severe acute respiratory syndrome. The devastating impact of this novel coronavirus …
[HTML][HTML] Drug repurposing for COVID-19: A review and a novel strategy to identify new targets and potential drug candidates
L Rodrigues, R Bento Cunha, T Vassilevskaia… - Molecules, 2022 - mdpi.com
In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the …
2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the …
Utilizing drug repurposing against COVID-19–efficacy, limitations, and challenges
V Parvathaneni, V Gupta - Life sciences, 2020 - Elsevier
The recent outbreak of Coronavirus disease (COVID-19), first in Eastern Asia and then
essentially across the world has been declared a pandemic by the WHO. COVID-19 is …
essentially across the world has been declared a pandemic by the WHO. COVID-19 is …
[HTML][HTML] Perspectives for repurposing drugs for the coronavirus disease 2019
SS Cherian, M Agrawal, A Basu… - Indian Journal of …, 2020 - journals.lww.com
The newly emerged 2019 novel coronavirus (CoV), named as severe acute respiratory
syndrome CoV-2 (SARS-CoV-2), like SARS-CoV (now, SARS-CoV-1) and Middle East …
syndrome CoV-2 (SARS-CoV-2), like SARS-CoV (now, SARS-CoV-1) and Middle East …